Podcast 75: Which regimen for hypertension?

Patients with hypertension at risk for cardiovascular events have done better with an ACE inhibitor-calcium channel blocker combination than with the ACE inhibitor plus hydrochlorothiazide. The ACCOMPLISH investigators have now reported on their analysis of progression-of-nephropathy outcomes in their trial. We interview the first author of the analysis, Dr. George Bakris of the University of Chicago’s Pritzker School of Medicine.

Interview-related links:

• NHLBI guidelines on managing hypertension
• Physician’s First Watch coverage of ACCOMPLISH analysis

News-related links:

• FDA warning on long-acting beta agonists
• Pipe- and cigar-smoking and COPD risk
• Metformin’s sometimes-offputting aroma
• Health statistics on the U.S.

The post Podcast 75: Which regimen for hypertension? first appeared on Clinical Conversations.